Sale!

UJVIRA 100

TRASTUZUMAB AND EMTANSINE 100mg

2-8* C
MRP : MRP 37,495.31
Price : 19,000.00
You Save : 18,495.31 (49.33%)

1 vial(s)

Buy Now

Ujvira 100mg Injection is a targeted cancer therapy that contains the active ingredient trastuzumab emtansine. It is specifically designed to treat patients with HER2-positive metastatic breast cancer who have already been treated with trastuzumab and chemotherapy. The U.S. Food and Drug Administration (FDA) approved this medication on February 22, 2013, recognizing its efficacy in managing advanced stages of HER2-positive breast cancer.

This medication is not intended for use in adolescents or children under the age of 18, as its safety and effectiveness in this population have not been established. Before initiating treatment with Ujvira 100mg Injection, it is important to inform your healthcare provider about any pre-existing conditions such as blood clotting disorders, liver problems, or known allergies to medications or components of this treatment. This information will help your doctor assess whether this medication is appropriate for you and minimize the risk of adverse effects